InvestorsHub Logo

tikotiko

05/09/20 3:42 PM

#76707 RE: ScienceOC #76706

Well, I think you made good use of the post!
Go Bruins, Dr. Yang and CYDY!

$5.95akadawson-m

05/09/20 5:03 PM

#76725 RE: ScienceOC #76706

I think I mentioned that Leronlimab was bought years ago.

Leronlimab (previously known as PRO140) is a humanized IgG4 targeting CCR5 which CytoDyn is progressing through multiple stages of clinical development for a variety of diseases, namely CCR5-tropic HIV infection, metastatic TNBC, metastatic colorectal cancer, nonalcoholic steatohepatitis (NASH), and graft-versus-host disease (GvHD) with a variety of preclinical studies ongoing in an oncology setting [66].

CytoDyn acquired leronlimab from Progenics Pharmaceuticals in 2012.

DJknows

05/09/20 5:09 PM

#76727 RE: ScienceOC #76706

Here's some interesting history/reading I was introduced to by lorbas a few days ago:

http://www.allendallen.com/Memorium-Allen-D-Allen.html

I believe Dr. Pourhassan came on board in 2012....



Hope you're having a good weekend, staying safe and very best to all with CYDY!